Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
95Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $606.88M | $-225.68M | $-0.30 |
| 2024 | $713.14M | $-53.22M | $-0.08 |
| 2023 | $863.50M | $-188.86M | $-0.25 |
| 2022 | $1.00B | $-328.40M | $-0.46 |
| 2021 | $1.77B | $-30.14M | $-0.05 |
Social Signal Score
Earnings
Wed, Nov 4(in 3 months)
Consensus estimate $-0.06 per share
Typical surprise +42.9% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Jul 27$-0.01 vs $-0.08beat
- Tue, Apr 28$-0.07 vs $-0.07beat
- Thu, Feb 26$-0.04 vs $-0.07beat
- Wed, Oct 29$0.03 vs $-0.02beat
- Thu, Jul 31$-0.19 vs $-0.12miss
- Wed, Apr 30$-0.10 vs $-0.06miss
Estimates and results for OPK via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
OPKhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsglobenewswire.com·2d ago·Neutral
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests Transaction provides additional non-dilutive capital and enhanced financial flexibility while preserving meaningful long-term royalty upside Transaction provides additional non-dilutive capital and enhanced financial flexibility while preserving meaningful long-term royalty upside
View source ↗